Cancer

2019 

 

 

2018 Aug

 

 

 

2017 Oct

1. Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance. Clinical Cancer Research 2016, Nov;22(21):5349-5361

3. Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer. Oncotarget. 2017 Jan 3;8(1):1481-1494.

5. Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors. Cancer Res. 2016 Dec 1;76(23):6851-6863.

7. QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas. Mod Pathol. 2016 Dec;29(12):1485-1491.

9. Chemotherapy-induced prospective memory impairment in breast cancer patients with different hormone receptor expression. Medicine. 2017 Mar;96(13):e6514.

11. Multinucleated Giant Cancer Cells Produced in Response to Ionizing Radiation Retain Viability and Replicate Their Genome. Int J Mol Sci. 2017 Feb 8;18(2).

14. In vitro anticancer activity of the laminarans from Far Eastern brown seaweeds and their sulfated derivatives. J Appl Phycol.2017 Feb;29(1):543-553

16. Quality of life and living with cancer: findings from the European social survey (2014) special module on the social determinants of health. Eur J Public Health. 2017 Feb;27:115-119.

18. The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells. Anticancer Res. 2016 Nov;36(11):5731-5742.

20. Increase of Intracellular Cyclic AMP by PDE4 Inhibitors Affects HepG2 Cell Cycle Progression and Survival. J Cell Biochem. 2017 Jun;118(6):1401-1411.

2. TFAP2C promotes lung tumorigenesis and aggressiveness through miR-183- and miR-33a-mediated cell cycle regulation. Oncogene. 2017 Mar;36(11):1585-1596.

4. Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events. J Cell Physiol. 2017 Jun;232(6):1368-1386.

6. Appetite Loss as an Adverse Effect During Treatment with EGFR-TKIs in Elderly Patients with Non-small Cell Lung Cancer. Anticancer Res. 2016 Sep;36(9):4951-4.

8. Detailed resolution analysis reveals spatial T cell heterogeneity in the invasive margin of colorectal cancer liver metastases associated with improved survival. Oncoimmunology. 2017 Feb 23;6(3):e1286436.

10. New IL-15 receptor-α splicing variants identified in intestinal epithelial Caco-2 cells. Innate Immun. 2017 Jan;23(1):44-53.

12. Synergistic effects between a copper-based metal Casiopeína III-ia and cisplatin. Eur J Med Chem. 2017 Mar 31;129:266-274.

15. Evaluation of the Response to Breast Cancer Neoadjuvant Chemotherapy Using 18F-FDG Positron Emission Mammography Compared With Whole-Body 18F-FDG PET: A Prospective Observational Study. Clin Nucl Med. 2017 Mar;42(3):169-175.

17. Design, synthesis and biological evaluation of 2(4phenylthiazol2yl)isoindoline1,3dione derivatives as anti-prostate cancer agents. Bioorg Med Chem Lett.2017 Mar;27(5):11991204.

19. A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma. J Mol Diagn. 2017 Jan;19(1):99-106.

21. The nerve growth factor alters calreticulin translocation from the endoplasmic reticulum to the cell surface and its signaling pathway in epithelial ovarian cancer cells. Int J Oncol. 2017 Apr;50(4):1261-1270.